Patents by Inventor Jonathan R. Hill

Jonathan R. Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100016654
    Abstract: The present invention relates to a method of minimizing immunological rejection of a nuclear transfer (“NT”) fetus which includes transferring a NT embryo into an embryo recipient under conditions effective for development of a NT fetus with minimal risk of immunological rejection of the fetus due to a maternal anti-fetal MHC-I immune response. After determining an MHC-I antigen type for a NT embryo and an MHC-I antigen type for embryo recipients, the NT embryo is either (i) transferred into a first embryo recipient having a compatible MHC-I antigen type under conditions effective for development of a NT fetus from the NT embryo, or (ii) transferred into a second embryo recipient having an incompatible MHC-I antigen type, followed by regulating MHC-I expression of the NT embryo or suppressing an immune response of the embryo recipient under conditions effective for development of a nuclear transfer fetus.
    Type: Application
    Filed: May 19, 2009
    Publication date: January 21, 2010
    Applicant: CORNELL RESEARCH FOUNDATION, INC
    Inventors: Christopher J. DAVIES, Donald H. SCHLAFER, Jonathan R. HILL
  • Publication number: 20040029825
    Abstract: The present invention relates to a method of minimizing immunological rejection of a nuclear transfer (“NT”) fetus which includes transferring a NT embryo into an embryo recipient under conditions effective for development of a NT fetus with minimal risk of immunological rejection of the fetus due to a maternal anti-fetal MHC-I immune response. After determining an MHC-I antigen type for a NT embryo and an MHC-I antigen type for embryo recipients, the NT embryo is either (i) transferred into a first embryo recipient having a compatible MHC-I antigen type under conditions effective for development of a NT fetus from the NT embryo, or (ii) transferred into a second embryo recipient having an incompatible MHC-I antigen type, followed by regulating MHC-I expression of the NT embryo or suppressing an immune response of the embryo recipient under conditions effective for development of a nuclear transfer fetus.
    Type: Application
    Filed: July 28, 2003
    Publication date: February 12, 2004
    Inventors: Christopher J Davies, Donald H Schlafer, Jonathan R HIll
  • Publication number: 20030158065
    Abstract: A conditioning shampoo composition comprised of a mixture of anionic and amphoteric surfactants and optional conditioners which imparts cleansing, wet detangling, dry detangling and manageability to hair and which is relatively non-irritating and thus suitable for use by young children and adults having sensitive skin and eyes.
    Type: Application
    Filed: October 16, 2002
    Publication date: August 21, 2003
    Inventors: Elvin R. Lukenbach, Victoria F. Dole, Glenn A. Nystrand, Laura Mc Culloch, William D. Allan, Jonathan R. Hill, Charles J. Taylor
  • Patent number: 6489286
    Abstract: A conditioning shampoo composition comprised of a mixture of anionic and amphoteric surfactants and optional conditioners which imparts cleansing, wet detangling, dry detangling and manageability to hair and which is relatively non-irritating and thus suitable for use by young children and adults having sensitive skin and eyes.
    Type: Grant
    Filed: January 19, 2000
    Date of Patent: December 3, 2002
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Elvin R. Lukenbach, Victoria F. Dole, Glenn A. Nystrand, Laura McCulloch, William D. Allan, Jonathan R. Hill, Charles J. Taylor
  • Patent number: 6090773
    Abstract: A conditioning shampoo composition comprised of a mixture of anionic and amphoteric surfactants and optional conditioners which imparts cleansing, wet detangling, dry detangling and manageability to hair and which is relatively non-irritating and thus suitable for use by young children and adults having sensitive skin and eyes.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: July 18, 2000
    Assignee: Johnson & Johnson Consumer Products, Inc.
    Inventors: Elvin R. Lukenbach, Victoria F. Dole, Glenn A. Nystrand, Laura McCulloch, William D. Allan, Jonathan R. Hill, Charles J. Taylor